CONMED Corporation

CONMED Corporation

CNMD

$45.52

Updated: 24/09/2026, 16:43:05

Market Cap
$1.36B
Sector
Healthcare
Industry
Medical - Devices
Country
US
Stock valuation chart
One-year closing share-price history for CNMD
Company Profile

CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.

USD
NYSE
CEO: Patrick J. Beyer
Employees: 3,900
https://www.conmed.com
Asset Summaries
Latest generated summaries for CNMD

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for CNMD.
Share price
$45.52
Market cap
$1.36B
Exchange
NYSE
Currency
USD
CEO
Patrick J. Beyer
Employees
3,900
IPO date
23/07/1987
Beta
0.907
Last dividend
$0.00
Day range
$45.42 – $45.95
52-week range
$31.44 – $53.66
1-day performance
-0.61%
1-year performance
44.78%
Current drawdown (1Y)
-15.17%
CIK
0000816956
CUSIP
207410101
ISIN
US2074101013
Created
07/12/2025, 03:23:25
Last update
24/09/2026, 16:43:05

Track CONMED Corporation with an AI analyst

See which prediction-market events move CNMD, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.